Over time this absorption problem can lead to other problems such as anemia, cardiovascular disease and more
The submission is supported by the SURPASS CVOT trial, which showed that Mounjaro reduced the risk of MACE including cardiovascular (CV) death, heart attack, or stroke by 8% compared with dulaglutide (Trulicity
But when combined with a GLP-1 medication, it has the potential to lead to blood sugar levels that are too low, resulting in hypoglycemia
Medical evaluation requirements Before pursuing PT-141 therapy, there are a few things to consider: Your Health Status : Cardiovascular health is particularly important Previous Treatment Responses : Have traditional ED medications been effective
Wegovy is FDA-approved for weight loss and, in March 2024, it became the first FDA-approved treatment to reduce the risk of major cardiovascular events in adults with overweight or obesity
An On Point producer then thoroughly reviewed, corrected, and reformatted the transcript before publication